1,127
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Cephaeline promotes ferroptosis by targeting NRF2 to exert anti-lung cancer efficacy

, , &
Pages 195-206 | Received 15 May 2023, Accepted 20 Jan 2024, Published online: 09 Feb 2024

References

  • Akter R, Najda A, Rahman M, Shah M, Wesołowska S, Hassan S, Mubin S, Bibi P, Saeeda S. 2021. Potential role of natural products to combat radiotherapy and their future perspectives. Molecules. 28(24):5997. doi: 10.3390/molecules28248091.
  • Ashrafizadeh M, Najafi M, Makvandi P, Zarrabi A, Farkhondeh T, Samarghandian S. 2020. Versatile role of curcumin and its derivatives in lung cancer therapy. J Cell Physiol. 235(12):9241–9268. doi: 10.1002/jcp.29819.
  • Balaji S, Terrero D, Tiwari A, Ashby C, Raman D. 2021. Alternative approaches to overcome chemoresistance to apoptosis in cancer. Adv Protein Chem Struct Biol. 126:91–122. doi: 10.1016/bs.apcsb.2021.01.005.
  • Camidge D, Doebele R, Kerr K. 2019. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC. Nat Rev Clin Oncol. 16(6):341–355. doi: 10.1038/s41571-019-0173-9.
  • Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L, Bastien E, Dessy C, Larondelle Y, Feron O. 2021. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 33(8):1701–1715.e1705. doi: 10.1016/j.cmet.2021.05.016.
  • Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C, Patel D, Bauer A, Cantley A, Yang W, et al. 2012. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 149(5):1060–1072. doi: 10.1016/j.cell.2012.03.042.
  • Dong H, Qiang Z, Chai D, Peng J, Xia Y, Hu R, Jiang H. 2020. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1. Aging (Albany NY). 12(13):12943–12959. doi: 10.18632/aging.103378.
  • Gao M, Yi J, Zhu J, Minikes A, Monian P, Thompson C, Jiang X. 2019. Role of mitochondria in ferroptosis. Mol Cell. 73(2):354–363.e353. doi: 10.1016/j.molcel.2018.10.042.
  • Gao S, Li N, Wang S, Zhang F, Wei W, Li N, Bi N, Wang Z, He J. 2020. Lung cancer in People’s Republic of China. J Thorac Oncol. 15(10):1567–1576. doi: 10.1016/j.jtho.2020.04.028.
  • Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, Mimura J, Toki T, Maher J, Yamamoto M, et al. 2011. Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys. 508(1):101–109. doi: 10.1016/j.abb.2011.02.001.
  • Hellyer J, Padda S, Diehn M, Wakelee H. 2021. Clinical implications of KEAP1-NFE2L2 mutations in NSCLC. J Thorac Oncol. 16(3):395–403. doi: 10.1016/j.jtho.2020.11.015.
  • Henning Y, Blind U, Larafa S, Matschke J, Fandrey J. 2022. Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction. Cell Death Dis. 13(7):662. doi: 10.1038/s41419-022-05121-z.
  • Hirschhorn T, Stockwell B. 2019. The development of the concept of ferroptosis. Free Radic Biol Med. 133:130–143. doi: 10.1016/j.freeradbiomed.2018.09.043.
  • Huang Z, Jing X, Sheng Y, Zhang J, Hao Z, Wang Z, Ji L. 2019. (-)-Epicatechin attenuates hepatic sinusoidal obstruction syndrome by inhibiting liver oxidative and inflammatory injury. Redox Biol. 22:101117. doi: 10.1016/j.redox.2019.101117.
  • Kerins M, Ooi A. 2018. The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal. 29(17):1756–1773. doi: 10.1089/ars.2017.7176.
  • Liang J, Wang D, Lin H, Chen X, Yang H, Zheng Y, Li Y. 2020. A novel ferroptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma. Int J Biol Sci. 16(13):2430–2441. doi: 10.7150/ijbs.45050.
  • Liu K, Ding L, Wu H. 2015. Bevacizumab in combination with anticancer drugs for previously treated advanced non-small cell lung cancer. Tumour Biol. 36(3):1323–1327. doi: 10.1007/s13277-014-2962-1.
  • Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, et al. 2021. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 593(7860):586–590. doi: 10.1038/s41586-021-03539-7.
  • Qian L, Wang F, Lu S, Miao H, He X, Feng J, Huang H, Shi R, Zhang J. 2022. A comprehensive prognostic and immune analysis of ferroptosis-related genes identifies SLC7A11 as a novel prognostic biomarker in lung adenocarcinoma. J Immunol Res. 2022:1951620. doi: 10.1155/2022/1951620.
  • Qiang W, Dai Y, Xing X, Sun X. 2022. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis. Cancer Med. 11(16):3168–3181. doi: 10.1002/cam4.4670.
  • Scalera S, Mazzotta M, Cortile C, Krasniqi E, De Maria R, Cappuzzo F, Ciliberto G, Maugeri-Saccà M. 2022. KEAP1-mutant NSCLC: the catastrophic failure of a cell-protecting Hub. J Thorac Oncol. 17(6):751–757. doi: 10.1016/j.jtho.2022.03.011.
  • Sha R, Xu Y, Yuan C, Sheng X, Wu Z, Peng J, Wang Y, Lin Y, Zhou L, Xu S, et al. 2021. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy. EbioMedicine. 71:103560. doi: 10.1016/j.ebiom.2021.103560.
  • Shin D, Kim E, Lee J, Roh J. 2018. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med. 129:454–462. doi: 10.1016/j.freeradbiomed.2018.10.426.
  • Silva L, Borgato G, Wagner V, Martins M, Rocha G, Lopes M, Santos-Silva A, de Castro Júnior G, Kowalski L, Nor J, et al. 2022. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells. J Oral Pathol Med. 51(6):553–562. doi: 10.1111/jop.13252.
  • Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249. doi: 10.3322/caac.21660.
  • Wang D, Wei G, Ma J, Cheng S, Jia L, Song X, Zhang M, Ju M, Wang L, Zhao L, et al. 2021. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. BMC Cancer. 21(1):645. doi: 10.1186/s12885-021-08341-2.
  • Wang H, Liu C, Zhao Y, Gao G. 2020. Mitochondria regulation in ferroptosis. Eur J Cell Biol. 99(1):151058. doi: 10.1016/j.ejcb.2019.151058.
  • Wang X, Sun Z, Villeneuve N, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak G, et al. 2008. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis. 29(6):1235–1243. doi: 10.1093/carcin/bgn095.
  • Wu J, Bao L, Zhang Z, Yi X. 2017. Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells. Oncotarget. 8(55):93502–93515. doi: 10.18632/oncotarget.19548.
  • Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D. 2016. Ferroptosis: process and function. Cell Death Differ. 23(3):369–379. doi: 10.1038/cdd.2015.158.
  • Yang Y, Bai L, Liao W, Feng M, Zhang M, Wu Q, Zhou K, Wen F, Lei W, Zhang N, et al. 2021. The role of non-apoptotic cell death in the treatment and drug-resistance of digestive tumors. Exp Cell Res. 405(2):112678. doi: 10.1016/j.yexcr.2021.112678.
  • Zhang L, Zhang J, Jin Y, Yao G, Zhao H, Qiao P, Wu S. 2021. Nrf2 is a potential modulator for orchestrating iron homeostasis and redox balance in cancer cells. Front Cell Dev Biol. 9:728172. doi: 10.3389/fcell.2021.728172.
  • Zhou B, Liu J, Kang R, Klionsky D, Kroemer G, Tang D. 2020. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 66:89–100. doi: 10.1016/j.semcancer.2019.03.002.
  • Zhu G, Huang H, Xu S, Shi R, Gao Z, Lei X, Zhu S, Zhou N, Zu L, Mello R, et al. 2021. Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma. Thorac Cancer. 12(12):1890–1899. doi: 10.1111/1759-7714.13998.